CEO of Madrigal Pharmaceuticals, Inc.
CEO of Madrigal Pharmaceuticals, Inc.
Current Market Cap
$6.70B
Number of Employees
376
No compensation data available for Mardi C. Dier yet. Come back soon!
Mardi C. Dier
CEO of Madrigal Pharmaceuticals, Inc.
Education
B.S. in biology from Stanford University; M.B.A. from UCLA.
Field of Expertise
Finance & Banking - Finance
Born
January 1, 1964 - 60 years ago
Is Founder?
No
Current Tenure
0 years 8 months (Mar 2024 - Present)
Previous Experience
CFO of Acelyrin, Inc.; CFO and Executive Vice President of Ultragenyx.